Millennium Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Millennium Management’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-270	Closed	-$16K	–	6189
2023 Q1	$16K	Buy	270 +11	+4%	+$139	﹤0.01%	5920
2022 Q4	$24K	Sell	259 -65	-20%	-$769	﹤0.01%	5998
2022 Q3	$39K	Sell	324 -44	-12%	-$756	﹤0.01%	6261
2022 Q2	$28K	Sell	368 -741	-67%	-$10.6K	﹤0.01%	6390
2022 Q1	$172K	Sell	1,109 -674	-38%	-$16.2K	﹤0.01%	5894
2021 Q4	$429K	Sell	1,783 -368	-17%	-$17.4K	﹤0.01%	5196
2021 Q3	$924K	Sell	2,151 -628	-23%	-$41.1K	﹤0.01%	4774
2021 Q2	$1.52M	Buy	+2,779	New	+$174K	﹤0.01%	4254
2019 Q3	–	Sell	-131	Closed	-$210K	–	4227
2019 Q2	$210K	Buy	+131	New	+$37.1K	﹤0.01%	3733

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management's KRSA Position: Q2 2023 in Review

Millennium Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 270 shares — an estimated $16K sold.

Millennium Management first reported a position in KRSA in Q2 2019 and held it in 9 quarters. The position peaked at $1.52M in Q2 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

Millennium Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 270 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $16K.
Millennium Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Millennium Management's Korsana Biosciences, Inc. Common Stock position peaked at $1.52M in Q2 2021.
17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.